Atlas Trials

Gastroesophageal Adenocarcinoma

31 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Gastroesophageal Adenocarcinoma

RecordFirmDate
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers (NCT05152147)Jazz Pharmaceuticals2021-12-02
Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins. (NCT04712721)Novartis Pharmaceuticals2021-10-14
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab (NCT05029882)AbbVie2021-10-13
ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer (NCT04602117)QuantumLeap Healthcare Collaborative2021-07-28
Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L) (NCT04021108)Weill Medical College of Cornell University2019-07-22
A Study of a Personalized Neoantigen Cancer Vaccine (NCT03639714)Gritstone bio, Inc.2019-02-13
A Study of Personalized Neoantigen Cancer Vaccines (NCT03794128)Gritstone bio, Inc.2018-07-25
Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma (NCT01757171)Weill Medical College of Cornell University2012-12-01
Panitumumab, Paclitaxel, Carboplatin and 5FU in the Treatment of Potentially Resectable Gastroesophageal Adenocarcinoma (NCT01182610)Accelerated Community Oncology Research Network2011-04-01
Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies (NCT01045421)Millennium Pharmaceuticals, Inc.2010-02-01
Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer (NCT00073502)OSI Pharmaceuticals2003-10-01

Track Gastroesophageal Adenocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.